Envoy Medical, Inc. filed 2 current reports with the SEC under Item 5.02, which covers directors and officers leaving or being appointed, the latest on 2026-08-27. Between them they name 2 people. Each change below is quoted from the filing and linked to it.
Every change, newest first
Appointed: Robert Potashnick, Chief Accounting Officer
Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers On August 24, 2026, Envoy Medical, Inc. (the "Company") appointed Robert Potashnick to serve as the Company's Chief Accounting Officer and Vice President of Finance.
Appointed: Charles S. McKhann, Director
Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers On April 15, 2026, upon the recommendation of the Nominating and Corporate Governance Committee of the Board of Directors (the " Board ") of Envoy Medical, Inc. (the " Company "), the Board appointed Charles S. McKhann to serve as a Class I director, with an initial term expiring at the Company's 2027 annual meeting of stockholders.
Find people with the same kind of experience as the Chief Accounting Officer at Envoy Medical, Inc., with the record behind each one.
Find candidates like Chief Accounting Officer at Envoy Medical, Inc.New leaders review vendors and budgets in their first months. Get an alert the next time Envoy Medical, Inc. is in the news or changes leadership.
Get an alert when Envoy Medical, Inc. changes leadershipTools for this story
Each opens in a new tab, filled in for Envoy Medical, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.